Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanovibronix Inc NAOV

Healthcare Medical Devices
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort... see more

Recent & Breaking News (NDAQ:NAOV)

NanoVibronix Provides Business Update

Business Wire 13 days ago

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

Business Wire October 9, 2024

NanoVibronix Signs Letter of Intent with Potential New Distributor

Business Wire September 23, 2024

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

Business Wire August 21, 2024

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

Business Wire May 22, 2024

NanoVibronix Issues Letter to Stockholders

Business Wire May 16, 2024

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

Business Wire May 14, 2024

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

Business Wire May 1, 2024

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

Accesswire April 24, 2024

NanoVibronix Issues Letter to Stockholders

Business Wire April 9, 2024

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Business Wire March 28, 2024

NanoVibronix Featured in Your Bladder Health Magazine

Business Wire December 6, 2023

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

Business Wire December 4, 2023

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

Business Wire November 28, 2023

NanoVibronix Regains Nasdaq Compliance

Business Wire November 21, 2023

NanoVibronix Issues Letter to Shareholders

Business Wire November 14, 2023

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

Business Wire November 7, 2023

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Business Wire September 27, 2023

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

Business Wire September 6, 2023

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Business Wire August 30, 2023